An observational study in Marfan Syndrome, Turner Syndrome and Ehlers-Danlos Syndrome, sponsored by National Heart, Lung, and Blood Institute (NHLBI). Completed at 7 sites in United States. Per ClinicalTrials.gov, last updated 2016-12-20.
Sponsored by National Heart, Lung, and Blood Institute (NHLBI) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Marfan Syndrome with a site in United States — 2 open to participants now, 3 under way, none of them phase 3. Marfan Syndrome · United States.
Among the 16 studies in Marfan Syndrome with a site in United States, this one is one of 3 that started in 2007, is one of 6 observational ones, and was the 5th registered.
61 studies on the registry are indexed under Marfan Syndrome; 15 are open to participants now.
Browse Marfan Syndrome studies →2 of the 16 studies in Marfan Syndrome with a site in United States are open now. Recruiting first, the newest first:
Baylor College of Medicine · Sites in United States
Ages 10–25
Andres Schanzer · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 12 Marfan Syndrome studies recruiting now, 7 (58%) set no upper age limit and 4 (33%) stop at 75 or younger; 9 take children under 18; 1 takes healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 3 started in 2007.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 3,706 is above the median of 144 across 34 observational studies indexed under Marfan Syndrome.
Median enrollment 45 across the 10 interventional studies, 915 across the 6 observational. Of the 10 that completed or were terminated, 2 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 16 have an industry lead sponsor. The 10 most frequent:
National Heart, Lung, and Blood Institute (NHLBI) is the lead sponsor of 1,144 studies on the registry; 71 are open to participants now.
Of its 58 completed or terminated interventional studies of FDA-regulated products, 51 (88%) have results posted.
National Heart, Lung, and Blood Institute (NHLBI) has 1 study filed under Marfan Syndrome — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Marfan Syndrome with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) was initiated in 2006 by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). GenTAC established a registry of 3706 patients with genetic conditions that may be related to thoracic aortic aneurysms and collected medical data and biologic samples. The study ended in September 2016. Data and samples are available from NHLBI and requests should be made to BioLINCC. See the NHLBI website for more information: https://www.nhlbi.nih.gov/research/resources/gentac/.
The cohort consists of patients with conditions related to genetically-induced thoracic aortic aneurysms.
Eligible subjects must have one of the conditions listed below and be enrolled in-person at one of the participating clinical centers.Contact the study coordinator at the location nearest you for more information about participation.
Exclusion Criteria:
Thoracic aortic aneurysms and dissections and their associated surgical interventions
Time frame: bi-annual
The record gives a start of Nov 2007, a primary completion of Sep 2015 and a completion of Sep 2016. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Heart, Lung, and Blood Institute (NHLBI) →